Literature DB >> 11919221

Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.

D Gancberg1, A Di Leo, G Rouas, T Järvinen, A Verhest, J Isola, M J Piccart, D Larsimont.   

Abstract

AIMS: Tumour tissue microarray allows the analysis of hundreds of tumour samples simultaneously on a single microscope slide. However, the extremely small tissue samples taken from the original tissue may not always be representative of the entire tumour.
METHODS: The reliability of this new technology was investigated by analysing HER-2 oncogene amplification by fluorescence in situ hybridisation (FISH) from representative slides of the whole tumour and small tissue core biopsies from 29 invasive breast tumours.
RESULTS: The tissue microarray method had high accuracy; in only one of 29 cases (3.4%; 95% confidence interval, 0% to 10%) were the results discordant with whole tumour analysis.
CONCLUSION: Tumour microarray is a highly reliable method for analysing HER-2 oncogene amplification by FISH in human breast tumours.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919221      PMCID: PMC1769624          DOI: 10.1136/jcp.55.4.315

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.

Authors:  E E Perrone; C Theoharis; N R Mucci; S Hayasaka; J M Taylor; K A Cooney; M A Rubin
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

2.  Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.

Authors:  A Nocito; L Bubendorf; E M Tinner; K Süess; U Wagner; T Forster; J Kononen; A Fijan; J Bruderer; U Schmid; D Ackermann; R Maurer; G Alund; H Knönagel; M Rist; M Anabitarte; F Hering; T Hardmeier; A J Schoenenberger; R Flury; P Jäger; J L Fehr; P Schraml; H Moch; M J Mihatsch; T Gasser; G Sauter
Journal:  J Pathol       Date:  2001-07       Impact factor: 7.996

3.  Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.

Authors:  A Hoos; M J Urist; A Stojadinovic; S Mastorides; M E Dudas; D H Leung; D Kuo; M F Brennan; J J Lewis; C Cordon-Cardo
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

Authors:  H Moch; P Schraml; L Bubendorf; M Mirlacher; J Kononen; T Gasser; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Validation of tissue microarray technology in breast carcinoma.

Authors:  R L Camp; L A Charette; D L Rimm
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

6.  Multiple tissue core arrays in histopathology research: a validation study.

Authors:  C E Gillett; R J Springall; D M Barnes; A M Hanby
Journal:  J Pathol       Date:  2000-12       Impact factor: 7.996

7.  Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.

Authors:  S Manley; N R Mucci; A M De Marzo; M A Rubin
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

8.  Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

Authors:  L Bubendorf; J Kononen; P Koivisto; P Schraml; H Moch; T C Gasser; N Willi; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

9.  Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.

Authors:  S Toikkanen; H Helin; J Isola; H Joensuu
Journal:  J Clin Oncol       Date:  1992-07       Impact factor: 44.544

10.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  10 in total

1.  Tissue microarrays for predictive molecular pathology.

Authors:  G Sauter; M Mirlacher
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

2.  A novel method for preparation of tissue microarray.

Authors:  Han-Lei Dan; Ya-Li Zhang; Yan Zhang; Ya-Dong Wang; Zuo-Sheng Lai; Yu-Jie Yang; Hai-Hong Cui; Yan-Ting Jian; Jian Geng; Yan-Qing Ding; Chun-Hai Guo; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Reply to "IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma".

Authors:  K Egervari; Z Szollosi; Z Nemes
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.

Authors:  Wenjin Chen; David J Foran
Journal:  Anal Chim Acta       Date:  2006-01-23       Impact factor: 6.558

5.  Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis.

Authors:  Jian-Xian Yu; Lin Cui; Qi-Yi Zhang; Hua Chen; Ping Ji; Hong-Jun Wei; Hai-Yan Ma
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

6.  Prognosis for Survival of Young Women with Breast Cancer by Quantitative p53 Immunohistochemistry.

Authors:  David E Axelrod; Kinsuk Shah; Qifeng Yang; Bruce G Haffty
Journal:  Cancer Clin Oncol       Date:  2012

7.  Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for HER-2/neu expression in breast carcinoma.

Authors:  Rani James; K Thriveni; Girija Ramaswamy; Lakshmi Krishnamoorthy; Geetashree Mukherjee; P P Vijayalaxmi Deshmane; P P Bapsy
Journal:  Indian J Clin Biochem       Date:  2008-12-20

8.  Testing for HER2 in Breast Cancer: A Continuing Evolution.

Authors:  Sejal Shah; Beiyun Chen
Journal:  Patholog Res Int       Date:  2010-12-06

9.  Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.

Authors:  Fan Zhang; Xingwu Yang; Lianhong Li; Lei Sun; B O Wang; Xiaotang Yu
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

10.  BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays.

Authors:  Abeer M Mahmoud; Virgilia Macias; Umaima Al-Alem; Ryan J Deaton; Andre Kadjaksy-Balla; Peter H Gann; Garth H Rauscher
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.